HOME > NATION > Article

Text Size

small

medium

large


Clinical Trial to Utilize Expired Blood to Start in Japan

Clinical Trial to Utilize Expired Blood to Start in Japan

   Kashihara, Nara Pref., Aug. 17 (Jiji Press)--Nara Medical University will begin a clinical trial in spring 2025 of artificial red blood cells made from donated blood past its shelf life that is usually discarded.
   A research team of the university in Nara Prefecture, western Japan, aims to put the artificial cells into practical use around 2030 amid growing interest in using such cells in the event of natural disasters and on remote islands.
   The practical use of such cells, if realized, is expected to be the world's first.
   Artificial red blood cells are produced by extracting hemoglobin, which carries oxygen, from donated blood and wrapping it with an artificial lipid membrane, according to the team.
   The artificial cells have a purplish color, unlike the common red color of blood, as they are made in a way that they do not oxidize until they are used.

To read a full story, please click here to find out how to subscribe.

NATION

HEADLINES

POLITICS
Japan, China, S. Korea Culture Ministers Agree to Promote Exchanges among Youth
ECONOMY
Niigata Starts Shipments of 2024 Koshihikari Rice amid Shortage in Stores
SPORTS
Sumo: Sekiwake Onosato Remains Undefeated on 5th Day of Autumn Grand Tournament
OTHER
China Stops Foreign Adoptions of Its Children in Late August after 3 Decades

AFP-JIJI PRESS NEWS JOURNAL


Photos